739 Results (Page 29 of 30)
Digital Health Markets Research Reports
Canada Digital Biomarkers Market Analysis
Canada Digital Biomarkers Market was valued at $232 Mn in 2023 and is predicted to grow at a CAGR of 22.3% from 2023 to 2030, to $949.45 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and increasing consumer health awareness. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
US Digital Biomarkers Market Analysis
US Digital Biomarkers Market was valued at $1,218 Mn in 2023 and is predicted to grow at a CAGR of 20.3% from 2023 to 2030, to $4,441.26 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and patient empowerment and engagement. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Saudi Arabia Digital Biomarkers Market Analysis
Saudi Arabia Digital Biomarkers Market was valued at $49.30 Mn in 2023 and is predicted to grow at a CAGR of 23.8% from 2023 to 2030, to $219.73 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and government initiatives. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
UAE Digital Biomarkers Market Analysis
UAE Digital Biomarkers Market was valued at $14.50 Mn in 2023 and is predicted to grow at a CAGR of 23.3% from 2023 to 2030, to $62.82 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, government initiatives, increased tech adoption, and focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Brazil Digital Biomarkers Market Analysis
Brazil Digital Biomarkers Market was valued at $72.50 Mn in 2023 and is predicted to grow at a CAGR of 23.3% from 2023 to 2030, to $314.11 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, and rising healthcare costs. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Mexico Digital Biomarkers Market Analysis
Mexico Digital Biomarkers Market was valued at $43.50 Mn in 2023 and is predicted to grow at a CAGR of 22.55% from 2023 to 2030, to $180.59 Mn by 2030. The key drivers of this industry include rising chronic disease burden, increased smartphone penetration, growing focus on preventative care, and government initiatives. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Spain Digital Biomarkers Market Analysis
Spain Digital Biomarkers Market was valued at $55.97 Mn in 2023 and is predicted to grow at a CAGR of 21.3% from 2023 to 2030, to $216.26 Mn by 2030. The key drivers of this industry include the high burden of chronic diseases, the advanced healthcare system, and the growing interest in personalized medicine. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
UK Digital Biomarkers Market Analysis
UK Digital Biomarkers Market was valued at $75.40 Mn in 2023 and is predicted to grow at a CAGR of 20.3% from 2023 to 2030, to $274.94 Mn by 2030. The key drivers of this industry include the high prevalence of chronic diseases, focus on preventative healthcare, government initiatives, and growing interest in personalized medicine. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
France Digital Biomarkers Market Analysis
France Digital Biomarkers Market was valued at $79.75 Mn in 2023 and is predicted to grow at a CAGR of 21.3% from 2023 to 2030, to $308.15 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, and rising healthcare costs. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Germany Digital Biomarkers Market Analysis
Germany Digital Biomarkers Market was valued at $106.14 Mn in 2023 and is predicted to grow at a CAGR of 20.5% from 2023 to 2030, to $391.55 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, and the focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
China Digital Biomarkers Market Analysis
China Digital Biomarkers Market was valued at $233.12 Mn in 2023 and is predicted to grow at a CAGR of 23.8% from 2023 to 2030, to $1,039.03 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, government initiatives, and a focus on personalized medicine. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Indonesia Digital Biomarkers Market Analysis
Indonesia Digital Biomarkers Market was valued at $17.40 Mn in 2023 and is predicted to grow at a CAGR of 22.3% from 2023 to 2030, to $71.21 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic diseases, government initiatives, and a growing focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Japan Digital Biomarkers Market Analysis
Japan Digital Biomarkers Market was valued at $180.26 Mn in 2023 and is predicted to grow at a CAGR of 22.8% from 2023 to 2030, to $759.08 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic diseases, the aging population, and the focus on innovation. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Malaysia Digital Biomarkers Market Analysis
Malaysia Digital Biomarkers Market was valued at $4.66 Mn in 2023 and is predicted to grow at a CAGR of 22.5% from 2023 to 2030, to $19.30 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic diseases, government initiatives, rising healthcare costs, and an aging population. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Philippines Digital Biomarkers Market Analysis
Philippines Digital Biomarkers Market was valued at $6.38 Mn in 2023 and is predicted to grow at a CAGR of 22.8% from 2023 to 2030, to $26.87 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, government initiatives, growing focus on preventative care, and the aging population. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Singapore Digital Biomarkers Market Analysis
Singapore Digital Biomarkers Market was valued at $3.48 Mn in 2023 and is predicted to grow at a CAGR of 22.9% from 2023 to 2030, to $14.74 Mn by 2030. The key drivers of this industry include a high disease burden, a tech-savvy population, government support, and a focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Vietnam Digital Biomarkers Market Analysis
Vietnam Digital Biomarkers Market was valued at $14.50 Mn in 2023 and is predicted to grow at a CAGR of 22.53% from 2023 to 2030, to $60.13 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, government initiatives, growing focus on preventative care, and the aging population. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Egypt Digital Biomarkers Market Analysis
Egypt Digital Biomarkers Market was valued at $8.12 Mn in 2023 and is predicted to grow at a CAGR of 23.8% from 2023 to 2030, to $36.19 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, government initiatives, and a growing focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Kenya Digital Biomarkers Market Analysis
Kenya Digital Biomarkers Market was valued at $2.03 Mn in 2023 and is predicted to grow at a CAGR of 23.4% from 2023 to 2030, to $8.85 Mn by 2030. The key drivers of this industry include a focus on expanding healthcare access, the growing prevalence of chronic diseases, and government initiatives. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
South Africa Digital Biomarkers Market Analysis
South Africa Digital Biomarkers Market was valued at $18.85 Mn in 2023 and is predicted to grow at a CAGR of 23.53% from 2023 to 2030, to $82.74 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic diseases, rising healthcare costs, and an aging population. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
India Digital Biomarkers Market Analysis
India Digital Biomarkers Market was valued at $52.74 Mn in 2023 and is predicted to grow at a CAGR of 25.3% from 2023 to 2030, to $255.74 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, increasing smartphone penetration, government initiatives, and a growing focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Brazil Physiotherapy Equipment Market Analysis
The Brazil Physiotherapy Equipment Market was valued at $522.50 Mn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $907.15 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are Cremer, BTL Industries, EMS Emefarma, and Enraf-Nonius BV among others
Canada Medical Digital Imaging System Market Analysis
The Canada Medical Digital Imaging System Market was valued at $2440 Mn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $4236.24 Mn by 2030. The key drivers of this industry include high prevalence of chronic disease, aging population, and technology advancements. The industry is primarily dominated by players such as Siemens, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
US Medical Digital Imaging System Market Analysis
The US Medical Digital Imaging System Market was valued at $12810 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $19517.35 Mn by 2030. The key drivers of this industry include the aging population, focus on preventive care, and technology advancements. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
UAE Medical Digital Imaging System Market Analysis
The UAE Medical Digital Imaging System Market was valued at $152.5 Mn in 2023 and is predicted to grow at a CAGR of 9.2% from 2023 to 2030, to $282.38 Mn by 2030. The key drivers of this industry include government initiatives, infrastructure development, and rising chronic diseases. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.